Model-Based, Goal-Oriented, Individualised Drug Therapy: Linkage of Population Modelling, New ‘Multiple Model’ Dosage Design, Bayesian Feedback and Individualised Target Goals

Author： Jelliffe R.W.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.34, Iss.1, 1998-01, pp. : 57-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Genetic Variation, Population Pharmacokinetic - Dynamic Models, Bayesian Feedback Control, and Maximally Precise Individualized Drug Dosage Regimens

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 4, 2009-12 ,pp. : 249-262

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic drug monitoring (TDM) and/or pharmacogenetic tests may be useful in devising individualised drug therapy regimens

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 6, 2007-06 ,pp. : 22-26

Adis International

Access to resources Recommend Favorite

The current role of model-based drug development

By Suryawanshi Satyendra   Zhang Liping   Pfister Marc   Meibohm Bernd  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 4, 2010-04 ,pp. : 311-321

Informa Healthcare

Access to resources Recommend Favorite

Pharmacodynamic Biomarkers in Model-Based Drug Development in Oncology

By  

Current Clinical Pharmacology, Vol. 6, Iss. 1, 2011-02 ,pp. : 30-40

Bentham Science Publishers

Access to resources Recommend Favorite

Population Pharmacokinetic Modelling and Design of a Bayesian Estimator for Therapeutic Drug Monitoring of Tacrolimus in Lung Transplantation

By Monchaud Caroline   de Winter Brenda C.  

Clinical Pharmacokinetics, Vol. 51, Iss. 3, 2012-03 ,pp. : 175-186

Adis International

Access to resources Recommend Favorite